Capital Flow Monitor · Sponsors · CIK 1650557
Genomenon, Inc.
206 E. Huron Street, ANN ARBOR, MI, 48104 · 734-794-3075
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$10.0M
Sold
$6.0M
% sold
60.3%
Investors
30
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-30 | D ·current | 506(b) | $10.0M | $6.0M | 60.3% | 30 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Michael Klein — Executive Officer / Director, Ann Arbor, MI
7 other raises
- Littlejohn M Co-Invest Fund, L.P. $0 of —
- Littlejohn Altitude Fund, L.P. $0 of —
- Littlejohn Altitude Feeder Fund (A), L.P. $0 of —
- LJ Pareto Co-Invest, L.P. $0 of —
- Aetos Sustainability Long/Short Fund, LP $4.2M of —
- Littlejohn Fund VII-A, L.P. $0 of —
- Littlejohn Fund VII, L.P. $0 of —
- Mark Kiel — Executive Officer / Director, Ann Arbor, MI
- Patricia Glaza — Director, Ann Arbor, MI
- David Gregorka — Director, Ann Arbor, MI
-
Michael Gross — Director, Ann Arbor, MI
6 other raises
- FlexEtc, Inc. $3.5M of $3.8M · 93.1%
- MGCP HLTH, LP $0 of —
- SLR Multi-Strategy Private Credit Fund III L.P. $0 of —
- SLR Multi-Strategy Private Credit Cayman Feeder Fund III L.P. $0 of —
- Fortune Bay Corp. $214K of $214K · 100.0%
- SLR HC Onshore Fund L.P. $418.4M of —
- Brian Groark — Executive Officer, Ann Arbor, MI
- Sam Globus — Executive Officer, Ann Arbor, MI
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.